Baby KJ's Gene Editing Clinical Trial
Baby KJ's medical team plans to ask the FDA to approve a clinical trial for a pioneering gene editing approach this winter.
The trial would be open to patients with seven different urea cycle disorders.
A Personal Story
Kyle Muldoon, Baby KJ's father, shared a heartwarming moment with his 1-year-old son while watching a football game.
“This is what we thought we would never get,”
Muldoon said, tearing up as he held his son, who was wearing an Eagles jersey.
Author's summary: Baby KJ's doctors to request FDA approval for gene editing trial.